Woerns, Marcus-Alexander; Galle, Peter R.
HEPATOCELLULAR CARCINOMA IN 2017 Two large steps forward, one small step backNATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. Bd. 15. H. 2. 2018 S. 75-76
Foerster, Friedrich; Galle, Peter Robert
Hepatocellular carcinoma: one world, one cancer-different guidelines?HEPATOBILIARY SURGERY AND NUTRITION. Bd. 7. H. 1. 2018 S. 41-43
Gehrke, Nadine; Hoevelmeyer, Nadine; Waisman, Ari et al.
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammationJOURNAL OF HEPATOLOGY. Bd. 68. H. 5. 2018 S. 986-995
Worns, Marcus-Alexander; Galle, Peter Robert
Hepatology Snapshot: Patient prioritisation in HCC treatment: All (good) things come in threesJOURNAL OF HEPATOLOGY. Bd. 68. H. 6. 2018 S. 1311-1312
Weinmann-Menke, J.; Weinmann, A.; Lutz, J.
Hepatorenal syndromeNEPHROLOGE. Bd. 13. H. 4. 2018 S. 277-286
Sprinzl, Martin; Kremer, Maximilian; Kohlwes, Elke et al.
HIGH-INTENSITY CONTRAST IMAGING ASSISTED HIGH-RESOLUTION ANOSCOPY WITH BLUE LIGHT IMAGING (BLI) FOR ANAL CARCINOMA SCREENING IN HIV INFECTED PATIENTSGASTROINTESTINAL ENDOSCOPY. Bd. 87. H. 6. 2018 S. AB381-AB381
Qin, S.; Cheng, A-L.; Ducreux, M. P. et al.
IMbrave150: A randomised phase III study of atezolizumab 1 bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinomaANNALS OF ONCOLOGY. Bd. 29. 2018
Finn, Richard S.; Ducreux, Michel; Qin, Shukui et al.
IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Weber, Matthias M.; Fottner, Christian
Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine NeoplasiaONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 306-312
Moehler, M.
Immuno-Oncology in gastric cancer: Soon standard? If so, for whom and when?ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 268-268